Researcher studying resistance to immune checkpoint blockade. Zaretsky and collaborators investigated acquired resistance to PD-1 blockade in melanoma, connecting changes in tumor cells with loss of therapeutic response.[ref]
Articles by others on the same topic
There are currently no matching articles.